Blastomycosis Surveillance in 5 States,United States, 1987–2018 |
| |
Authors: | Kaitlin Benedict Suzanne Gibbons-Burgener Anna Kocharian Malia Ireland Laura Rothfeldt Natalie Christophe Kimberly Signs Brendan R. Jackson |
| |
Affiliation: | Centers for Disease Control and Prevention, Atlanta, Georgia, USA (K. Benedict, B.R. Jackson);Wisconsin Department of Health Services, Madison, Wisconsin, USA (S. Gibbons-Burgener, A. Kocharian);Minnesota Department of Health, St. Paul, Minnesota, USA (M. Ireland);Arkansas Department of Health, Little Rock, Arkansas, USA (L. Rothfeldt);Louisiana Department of Health, Lafayette, Louisiana, USA (N. Christophe);Michigan Department of Health and Human Services, Lansing, Michigan, USA (K. Signs) |
| |
Abstract: | Blastomycosis is caused by inhalation of Blastomyces spp. fungi. Limited data are available on the incidence and geographic range of blastomycosis in the United States. To better characterize its epidemiologic features, we analyzed combined surveillance data from the 5 states in which blastomycosis is reportable: Arkansas, Louisiana, Michigan, Minnesota, and Wisconsin. Surveillance identified 4,441 cases during 1987–2018, a mean of 192 cases per year. The mean annual incidence was <1 case/100,000 population in most areas but >20 cases/100,000 population in some northern counties of Wisconsin. Median patient age was 46 years, 2,892 (65%) patients were male, 1,662 (57%) were hospitalized, and 278 (8%) died. The median time from symptom onset to diagnosis was 33 days. The severity of illness and diagnostic delays suggest that surveillance underestimates the true number of cases. More in-depth surveillance in additional states could elucidate blastomycosis incidence and inform efforts to increase awareness. |
| |
Keywords: | Blastomycosis epidemiology surveillance fungi pneumonia respiratory diseases United States Arkansas Louisiana Michigan Minnesota Wisconsin |
|
|